Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Psychosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    192 result(s) found for: Psychosis. Displaying page 1 of 10.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2007-003035-22 Sponsor Protocol Number: ACP-103-015 Start Date*: 2008-11-05
    Sponsor Name:ACADIA Pharmaceuticals Inc.
    Full Title: A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease
    Medical condition: Psychosis in Parkinson's Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004873 10037241 Psychosis NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FR (Completed) SE (Completed) BE (Completed) AT (Completed) PT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-003512-12 Sponsor Protocol Number: ACP-103-041 Start Date*: 2017-07-21
    Sponsor Name:ACADIA Pharmaceuticals Inc.
    Full Title: An Open-Label Extension Study to Examine the Safety and Tolerability of Pimavanserin in the Treatment of Parkinson’s Disease Psychosis
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004873 10037241 Psychosis NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001606-66 Sponsor Protocol Number: OLZvsLMT-DB Start Date*: 2005-06-16
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
    Full Title: OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS
    Medical condition: EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS
    Disease: Version SOC Term Classification Code Term Level
    6.1 10057667 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-000034-42 Sponsor Protocol Number: 2022-001 Start Date*: 2022-04-22
    Sponsor Name:Aarhus University Hospital - Psychiatry, Department of Affective Disorders
    Full Title: The Estimated 12-Hour Serum Lithium Level Pilot Study
    Medical condition: Bipolar disorder Unipolar Depression
    Disease: Version SOC Term Classification Code Term Level
    20.0 10037175 - Psychiatric disorders 10004938 Bipolar disorders HLT
    21.1 10037175 - Psychiatric disorders 10057667 Bipolar disorder PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003051-36 Sponsor Protocol Number: ACP-103-014 Start Date*: 2008-09-10
    Sponsor Name:Acadia Pharmaceuticals Inc
    Full Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease
    Medical condition: Psychosis in Parkinson's Disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037241 Psychosis NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended) ES (Completed) SE (Prematurely Ended) BE (Completed) PT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004893-84 Sponsor Protocol Number: CBD-P Start Date*: 2019-08-22
    Sponsor Name:Mental Health Center Glostrup
    Full Title: Cannabidiol for treatment of non-affective psychosis and cannabis use
    Medical condition: Non-affective psychosis and lifetime cannabis use
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004873 10037234 Psychosis LLT
    21.1 100000004869 10070996 Cannabis use LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002906-23 Sponsor Protocol Number: ACP-103-012 Start Date*: 2007-11-14
    Sponsor Name:Acadia Pharmaceuticals Inc
    Full Title: A Multi-Center, Placebo-Controlled, Double-Blind Trial To Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease
    Medical condition: Psychosis in Parkinson's Disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037241 Psychosis NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FR (Completed) BG (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002608-13 Sponsor Protocol Number: KCL/KCH-CT2004-1 (26/8/04) Start Date*: 2005-05-16
    Sponsor Name:King’s College London & King’s College Hospital
    Full Title: Pragmatic Randomised Control Trial of Quetiapine for psychosis in Parkinson’s Disease
    Medical condition: Parkinson's Disease with psychosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-000465-31 Sponsor Protocol Number: CannaBiD Start Date*: 2016-06-29
    Sponsor Name:Charité - Universitätsmedizin Berlin
    Full Title: Cannabidiol in Bipolar Depression – CannaBiD-Study: An 8-week randomized, double-blind, placebo-controlled clinical trial of Cannabidiol as add-on therapy in bipolar depression
    Medical condition: Bipolar disorder, current episode depressed
    Disease: Version SOC Term Classification Code Term Level
    19.0 10037175 - Psychiatric disorders 10004936 Bipolar depression LLT
    19.0 10037175 - Psychiatric disorders 10057667 Bipolar disorder PT
    19.0 10037175 - Psychiatric disorders 10026756 Manic depressive illness LLT
    19.0 10037175 - Psychiatric disorders 10026755 Manic depressive LLT
    19.0 10037175 - Psychiatric disorders 10004911 Bipolar affective disorder, depressed LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022184-35 Sponsor Protocol Number: ATLAS Start Date*: 2011-10-04
    Sponsor Name:King's College London [...]
    1. King's College London
    2. South London and Maudsley NHS Foundation Trust
    Full Title: A pragmatic randomised double-blind trial of Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis: The ATLAS Trial
    Medical condition: late-onset schizophrenia-like psychosis
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004873 10037234 Psychosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-001599-23 Sponsor Protocol Number: SIMPET-1 Start Date*: 2016-06-27
    Sponsor Name:University Medical Center Groningen
    Full Title: In Vivo Imaging of Neuroinflammation in Simvastatin-Treated Schizophrenic Patients
    Medical condition: Schizophrenia
    Disease: Version SOC Term Classification Code Term Level
    18.0 10037175 - Psychiatric disorders 10039626 Schizophrenia PT
    18.0 10037175 - Psychiatric disorders 10039621 Schizoaffective disorder PT
    18.0 10037175 - Psychiatric disorders 10039647 Schizophreniform disorder PT
    18.0 10037175 - Psychiatric disorders 10037241 Psychosis NOS LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-011343-39 Sponsor Protocol Number: RIS-SCH-4226 Start Date*: 2009-06-15
    Sponsor Name:Janssen-Cilag AB
    Full Title: Patient and physician preferences and satisfaction with oral and long-acting injectable long-term antipsychotic treatment for psychotic disorders
    Medical condition: Schizophrenia, schizoaffective disorder, delusional disorder, psychotic disorder NOS or any other psychotic disorder patients demanding long term antipsychotic treatment
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037253 Psychotic disorder NOS LLT
    9.1 10061920 Psychotic disorder LLT
    9.1 10039628 Schizophrenia and other psychotic disorders HLGT
    9.1 10012256 Delusional disorders HLT
    9.1 10039621 Schizoaffective disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2020-003972-42 Sponsor Protocol Number: A1281198 Start Date*: 2020-08-21
    Sponsor Name:Pfizer, Inc.
    Full Title: A PHASE 3, MULTICENTER, FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPO...
    Medical condition: Bipolar Disorder
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004873 10004938 Bipolar disorders HLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2009-011253-40 Sponsor Protocol Number: PQ2 Start Date*: 2009-04-23
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
    Full Title: Paroxetine or Quetiapine in Addition to Mood Stabilizers in Bipolar Depression
    Medical condition: Major Depressive Episode in Bipolar Disorder
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004908 Bipolar affective disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023740-32 Sponsor Protocol Number: 2010-023740-32 Start Date*: 2011-05-18
    Sponsor Name:Haukeland University Hospital [...]
    1. Haukeland University Hospital
    2.
    Full Title: Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder
    Medical condition: The goal of this work is to identify genes associated with good response of bipolar patients to two commonly used mood stabilizing agents, lithium and valproate. 1. All patients will be started on ...
    Disease: Version SOC Term Classification Code Term Level
    14.0 10037175 - Psychiatric disorders 10004908 Bipolar affective disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-018195-33 Sponsor Protocol Number: D1443L00079 Start Date*: 2010-05-11
    Sponsor Name:Centro de Investigación Biomédica en Red en el Área de Salud Mental (CIBERSAM)
    Full Title: Eficacia de quetiapina de liberación prolongada vs. placebo como terapia coadyuvante al tratamiento eutimizante en el control de los síntomas subsindrómicos del trastorno bipolar
    Medical condition: Terapia coadyuvante en el control de los síntomas subsindrómicos del trastorno bipolar
    Disease: Version SOC Term Classification Code Term Level
    11 10057667 Trastorno  bipolar LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-004746-81 Sponsor Protocol Number: Start Date*: 2009-07-20
    Sponsor Name:Parnassia-BAVO groep [...]
    1. Parnassia-BAVO groep
    2. St. Elisabeth Ziekenhuis
    3. University Medical Center Utrecht
    Full Title: Effect of amiloride on lithium-induced chronic nephropathy. Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment.
    Medical condition: Renal failure due to long-term use of lithium salts in patients with bipolar disorders.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004938 Bipolar disorders HLT
    9.1 10009121 Chronic renal failure worsened LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-004088-26 Sponsor Protocol Number: A1281201 Start Date*: 2020-09-03
    Sponsor Name:Pfizer, Inc.
    Full Title: 26-WEEK OPEN-LABEL EXTENSION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER (MOST RECENT EPISODE MANIC)
    Medical condition: Bipolar Disorder
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004873 10004938 Bipolar disorders HLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2008-000370-20 Sponsor Protocol Number: 2448/2007 Start Date*: 2008-08-05
    Sponsor Name:AZIENDA OSPEDALIERA PISANA
    Full Title: Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders.
    Medical condition: bipolar disorders
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057667 Bipolar disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-004872-31 Sponsor Protocol Number: SCA102833 Start Date*: 2016-12-21
    Sponsor Name:GlaxoSmithKline
    Full Title: The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age
    Medical condition: Bipolar Disorder
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004873 10004938 Bipolar disorders HLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 01:03:57 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA